INSTITUTIONAL DIMENSION OF INTERNATIONAL PHARMACEUTICAL SELF-REGULATION

Authors

  • B. P. Hromovyk Danylo Halytskyi Lviv National Medical University
  • O. B. Pankevych Danylo Halytskyi Lviv National Medical University

DOI:

https://doi.org/10.11603/2312-0967.2017.1.7530

Keywords:

self-government, International Pharmaceutical Federation, Pharmaceutical Group of the European Union, the European association of hospital pharmacists, pharmaceutical societies, All-Ukrainian Pharmaceutical Chamber, institutional dimension.

Abstract

The aim of the study. Research of self-regulation institutional frameworks for pharmaceutical practice (SR PP) in the international aspect.

Materials and Methods. Scientic publications, related with self-regulation, ofcial websites of international pharmaceutical associations and methodology of institutional dimension.

Results and Discussion. According to the references the historical background of the formation of the SR PP is revealed. By studying institutional frameworks of SR PP in the international aspect, it is founded that almost one third of countries, professional organizations of which are members of the International Pharmaceutical Federation (FIP), represented Europe. It is shown that just over half of the UN members by trade unions are member states of FIP, while two-thirds of European UN member states are members of the FIP. Based on a comparative study of the members' structure of the IPF, Pharmaceutical Group of the European Union (PGEU) and the European association of hospital pharmacists (EAHP). In a total it is found that in three investigated associations are presented 94 pharmaceutical organizations from 39 European countries. Herewith, in each pharmaceutical association the members are pharmaceutical societies of two third countries. Only four professional organizations are members of three pharmaceutical associations simultaneously, namely: Pharmaceutical Chamber of Macedonia, Croatian Pharmaceutical Society, Pharmaceutical Society of Bosnia and Herzegovina Federation and Turkish Pharmacists Association. Data for institutional dimension show signi cantly low participation activity of Ukrainian pharmaceutical societies' in the international associations. Herein, on condition of statutory documents' bringing to the requirements of a specic association, is opened their access not only to the FIP (Ukraine is a member of UN and WHO), but also yet PGEU (our state is a member of the European Free Trade Association) and EAHP (Ukraine is a member of the Council of Europe).

Conclusions. The obtained results show different levels of membership in the three international pharmaceutical associations (FIP, PGEU and EAHP) as states, and as well as separate pharmaceutical societies, and extremely low Ukrainian pharmaceutical societies' participation in SR PP in the international aspect.

Author Biographies

B. P. Hromovyk, Danylo Halytskyi Lviv National Medical University

Danylo Halytskyi Lviv National Medical University

O. B. Pankevych, Danylo Halytskyi Lviv National Medical University

Danylo Halytskyi Lviv National Medical University

References

Tsyvilnyi kodeks Ukrainy (redaktsiia vid 02.11.2016): Available from: http://zakon2.rada.gov.ua/laws/show/435-15.

Hromovyk BP, Unhurian LM. [Association of enterprises and public organizations as subjects of national self-regulation of the pharmaceutical market]. Ukr med almanakh. 2012;5: 86-9. Ukrainian.

Hromovyk BP, Pankevych OB. On the question of formation and functioning of the pharmaceutical self-government in Ukraine. [До питання формування і функціонування системи фармацевтичного самоврядування в Україні] Kharkiv: National University of Pharmacy; 2016. Ukrainian.

Nazarkina VM, Khomenko VM, Susharina IV. Study of approaches to the introduction of self-regulation in pharmacy. [Дослідження підходів до впровадження саморегулювання у фармації] Kharkiv: National University of Pharmacy; 2015. Ukrainian.

Susharyna IV, Nemchenko AS, Khomenko VM. [Scientic-methodical approaches to evaluating the performance of public organizations in pharmacy]. Management, Economics and Quality Assurance in Pharmacy. 2016;3: 68-74. Ukrainian.

Unhurian LM. [The role of public organizations and business entities in the self-regulation of pharmacy practice in Ukraine]. Vestnik of the South Kazakhstan state pharmaceutical academy. 2014; 2: 19-25.

Bondar O. [The institutional dimension of local government]. Education of the region, political science, psychology, communication. 2011;4: 166-170.

Srednevekovaia medytsyna i farmatsyia. Available from: http://www.pharmspravka.ru/pharmhistory/farmacija- srednevekovja/srednevekovaya-medicina-i-farmaciya.html.

Meriwether MA The role of the State in the regulation of pharmacy. Report Honolulu: University of Hawaii, Legisla-tive Reference Bureau, 1963;4: 159.

Chto predstavliala soboi farmatsyia v Evrope v XV-XVII vv. Available from: http://pharmspravka.ru/farmat-sevticheskie-vorosyi-i-otvetyi/chto/chto-predstavlyala-so-boy-farmatsiya-v-evrope-v-xv-xvii.html.

A History of Pharmacy in Pictures. Available from: https://www.pharmacy.wsu.edu/history/A%20History%20 of%20Pharmacy%20in%20Pictures.pdf.

Hryha NP, Hulenko MP [History Galician Pharmaceutical companies and pharmacists Hremium Galicia]. Scientic and technical bulletin. 2015;16: 436-438.

Głowacki W. Dawne organizacje zawodowe aptekarzy polskich. Farmacja Polska. 1964;3–4: 77-79.

International Pharmaceutical Federation (FIP). Available from: http://www. p.org/membership?page=membership_ organizations.

Sniehirov P. Ukraine – in the world pharmaceutical family. NGO "All Ukrainian Pharmaceutical Chamber" - a member of FIP. Available from: http://www.apteka.ua/ar-ticle/345865.

Pharmaceutical Group of the European Union. Available from: http://www.pgeu.eu/en/.

European Association of Hospital Pharmacists. Available from: http://www.eahp.eu./

Published

2017-03-24

How to Cite

Hromovyk, B. P., & Pankevych, O. B. (2017). INSTITUTIONAL DIMENSION OF INTERNATIONAL PHARMACEUTICAL SELF-REGULATION. Pharmaceutical Review Farmacevtičnij časopis, (1), 45–53. https://doi.org/10.11603/2312-0967.2017.1.7530

Issue

Section

Organization of pharmaceutical structures’ work